Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
June 26, 2020
Current and Emerging Biomarkers Predicting Bone Metastasis Development
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Journal of Hematology & Oncology
|
September 19, 2012
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
Bruno Vincenzi, Andrea Napolitano, Alice Zoccoli, et al.
Cancers
|
September 1, 2019
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, et al.
Biology
|
August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
Michele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Scientific Reports
|
January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
Francesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?
Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
November 8, 2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials
Sergio Rizzo, Antonio Galvano, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
March 23, 2017
Determinants of bone specific metastasis in prostate cancer
Paolo Manca, Francesco Pantano, Michele Iuliani, et al.
International Journal of Molecular Sciences
|
March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
June 26, 2020
Current and Emerging Biomarkers Predicting Bone Metastasis Development
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Journal of Hematology & Oncology
|
September 19, 2012
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
Bruno Vincenzi, Andrea Napolitano, Alice Zoccoli, et al.
Cancers
|
September 1, 2019
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2024
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, et al.
Biology
|
August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
Michele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Scientific Reports
|
January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
Francesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?
Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
November 8, 2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials
Sergio Rizzo, Antonio Galvano, Francesco Pantano, et al.
Critical Reviews in Oncology/Hematology
|
March 23, 2017
Determinants of bone specific metastasis in prostate cancer
Paolo Manca, Francesco Pantano, Michele Iuliani, et al.
International Journal of Molecular Sciences
|
March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Page
of 5